Lenient versus Strict Rate Control in Patients with Atrial Fibrillation
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Rate control is often the therapy of choice for atrial fibrillation. Guidelines recommend strict rate control, but this is not based on clinical evidence. We hypothesized that lenient rate control is not inferior to strict rate control for preventing cardiovascular morbidity and mortality in patients with permanent atrial fibrillation. METHODS: We randomly assigned 614 patients with permanent atrial fibrillation to undergo a lenient rate-control strategy (resting heart rate <110 beats per minute) or a strict rate-control strategy (resting heart rate <80 beats per minute and heart rate during moderate exercise <110 beats per minute). The primary outcome was a composite of death from cardiovascular causes, hospitalization for heart failure, and stroke, systemic embolism, bleeding, and life-threatening arrhythmic events. The duration of follow-up was at least 2 years, with a maximum of 3 years. RESULTS: The estimated cumulative incidence of the primary outcome at 3 years was 12.9% in the lenient-control group and 14.9% in the strict-control group, with an absolute difference with respect to the lenient-control group of -2.0 percentage points (90% confidence interval, -7.6 to 3.5; P<0.001 for the prespecified noninferiority margin). The frequencies of the components of the primary outcome were similar in the two groups. More patients in the lenient-control group met the heart-rate target or targets (304 [97.7%], vs. 203 [67.0%] in the strict-control group; P<0.001) with fewer total visits (75 [median, 0], vs. 684 [median, 2]; P<0.001). The frequencies of symptoms and adverse events were similar in the two groups. CONCLUSIONS: In patients with permanent atrial fibrillation, lenient rate control is as effective as strict rate control and is easier to achieve. (ClinicalTrials.gov number, NCT00392613.)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There was no difference in a composite of clinical events (14.9% in the strict rate control group, 12.9% in the lenient group), 560 NYHA class, or hospitalizations.560, 561”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [560]
Citations
Cites
Gage, B. F., Waterman, A. D., Shannon, W., Boechler, M., Rich, M. W., & Radford, M. J. (2001) · JAMA · doi:10.1001/jama.285.22.2864 · Cited by 4,832
A comparison of rate control and rhythm control in patients with atrial fibrillation
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa021328 · Cited by 4,405
Fuster, V., Rydén, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.177292 · Cited by 2,805
Self-citationVan Gelder, I. C., Hagens, V. E., Bosker, H. A., Kingma, J. H., Kamp, O., Kingma, T., Said, S. A., Darmanata, J. I., Timmermans, A. J. M., Tijssen, J. G. P., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021375 · Cited by 2,359
Self-citationEffect of Dronedarone on Cardiovascular Events in Atrial Fibrillation
Hohnloser, S. H., Crijns, H. J. G. M., van Eickels, M., Gaudin, C., Page, R. L., Torp-Pedersen, C., & Connolly, S. J. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0803778 · Cited by 1,129
Self-citationAtrial Fibrillation and Heart Failure: Treatment Considerations for a Dual Epidemic
Anter, E., Jessup, M., & Callans, D. J. (2009) · Circulation · doi:10.1161/circulationaha.108.821306 · Cited by 678
Lechat, P., Hulot, J.-S., Escolano, S., Mallet, A., Leizorovicz, A., Werhlen-Grandjean, M., Pochmalicki, G., & Dargie, H. (2001) · Circulation · doi:10.1161/01.cir.103.10.1428 · Cited by 525
Nerheim, P., Birger-Botkin, S., Piracha, L., & Olshansky, B. (2004) · Circulation · doi:10.1161/01.cir.0000135472.28234.cc · Cited by 378
Van Gelder, I. C., Crijns, H. J. G. M., Blanksma, P. K., Landsman, M. L. J., Posma, J. L., Van Den Berg, M. P., Meijler, F. L., & Lie, K. I. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90352-d · Cited by 269
Self-citationConnolly, S. J., Crijns, H. J. G. M., Torp-Pedersen, C., van Eickels, M., Gaudin, C., Page, R. L., & Hohnloser, S. H. (2009) · Circulation · doi:10.1161/circulationaha.109.875252 · Cited by 261
Self-citation
Cited by
Items 901–999 of 999
Hanna, E. B. (2022) · Wiley eBooks · doi:10.1002/9781119832737.ch10
The Year in Clinical Cardiac Electrophysiology
Marcus, G. M., Scheinman, M. M., & Keung, E. C. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.05.058
“(1) published the RACE II (Rate Control Efficacy in Permanent Atrial Fibrillation II) trial, the first formal assessment of alternative rate control goals in AF.”
BackgroundMethodCare of the patient with cardiac arrhythmias
Lee, G., Fålun, N., Angus, N. J., Hendriks, J., Norekvål, T. M., Berg, S. K., & Fitzsimons, D. (2021) · Oxford University Press eBooks · doi:10.1093/med/9780198849315.003.0007
Active Supraventricular Arrhythmias
de Luna, A. B., & FCCS, A. B. M. F. F. (2017) · Wiley eBooks · doi:10.1002/9781119212782.ch4
Bajpai, A., & Camm, A. J. (2012) · Wiley eBooks · doi:10.1002/9781118451786.ch5
Bajpai, A., & Camm, A. J. (2012) · Wiley eBooks · doi:10.1002/9781119952930.ch36
Drug therapy for atrial fibrillation --Limitations and future prospects--
三田村秀雄, 杉薫, 祐二, 中., 隆徳, 池., 之宏, 是., & 浩一郎, 熊. (2012) · Japanese Journal of Electrocardiology · doi:10.5105/jse.32.208
Lam, J. C., Stevenson, B., Lee, Y. G., Maurer, J., Patanwala, A. E., & Radosevich, J. J. (2022) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000001238
Camm, C. F., & Camm, A. J. (2022) · Wiley eBooks · doi:10.1002/9781119484288.ch29
Management of Atrial Fibrillation in the Outpatient Setting
Kaplinskiy, V., & Gelfand, E. V. (2022) · Springer eBooks · doi:10.1007/978-3-030-88953-1_23
Niederdöckl, J. D., Simon, A., Buchtele, N., Schütz, N., Cacioppo, F., Oppenauer, J., Gupta, S., Lutnik, M., Schnaubelt, S., Spiel, A. O., et al. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12040544
“Basically, there is no clear evidence of a long-term benefit of rhythm control over rate control [6,7].”
BackgroundBarrett, C. D., Kim, R., Sink, E. M., Tumolo, A. Z., Zipse, M. M., Aleong, R. G., Garg, L., Sandhu, A., West, J. J., Varosy, P. D., et al. (2022) · doi:10.2196/preprints.38097
Evaluation and Interventional Management of Cardiac Dysrhythmias.
Hoff, S. (2022) · Surgical Clinics of North America · doi:10.1016/j.suc.2022.01.003
Mihajlovic, M., Šimić, J., Marinković, M. M., Mujović, N. M., Prostran, M. S., & Potpara, T. (2022) · Galenika Medical Journal · doi:10.5937/galmed2201093m
(2012) · Elsevier eBooks · doi:10.1016/b978-0-323-08373-7.00010-8
Hanna, E. B. (2017) · Wiley eBooks · doi:10.1002/9781119233503.ch10
Extramiana, F., MESSALI, A., Labbé, J.-P., & Leenhardt, A. (2013) · EMC - Tratado de Medicina · doi:10.1016/s1636-5410(13)65325-8 · Cited by 1
Atrial Fibrillation and Other Supraventricular Tachycardias
Sedehi, D. (2020) · Springer eBooks · doi:10.1007/978-3-030-26710-0_16
Extramiana, F., MESSALI, A., Labbé, J.-P., & Leenhardt, A. (2013) · EMC - Traité de médecine AKOS · doi:10.1016/s1634-6939(13)59279-9
昌文, 渡., & 良三, 永. (2011) · Journal of JCS Cardiologists · doi:10.1253/jjcsc.19.1_111
Manuel, A. M., Almeida, J. G., Fonseca, P., Monteiro, J. P., Guerreiro, C., Barbosa, A. R., Teixeira, P., Ribeiro, J., Santos, E., Rosas, F., et al. (2021) · Revista Portuguesa de Cardiologia (English Edition) · doi:10.1016/j.repce.2020.05.025
尾長谷, 喜., Okura, H., & 清, 吉. (2012) · Journal of JCS Cardiologists · doi:10.1253/jjcsc.20.1_116
(2010) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-010-1127-3
KHAN, M. G. (2014) · Contemporary cardiology · doi:10.1007/978-1-61779-962-4_14
Kinugawa, K. (2020) · Springer eBooks · doi:10.1007/978-981-15-4843-7_1
Implications of Atrial Fibrillation in Heart Failure Management
Darling, C. E., & McManus, D. D. (2017) · Contemporary cardiology · doi:10.1007/978-3-319-44006-4_21
New trends in rate control of atrial fibrillation (What is the optimal heart rate and which case?)
Mitamura, H., 薫, 杉., 清水, 渉., 隆徳, 池., 英一, 渡., 尚彦, 高., & Takatsuki, S. (2011) · Japanese Journal of Electrocardiology · doi:10.5105/jse.31.213
Ambulatory Electrocardiography
Rho, R. W., & Page, R. L. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0285-9.00071-5
Rhythmusmanagement bei Vorhofflimmern
Metzner, A., Gunawardene, M., & Willems, S. (2022) · Nervenheilkunde · doi:10.1055/a-1822-1085
Nisbet, A. M., & Connelly, D. T. (2022) · Oxford University Press eBooks · doi:10.1093/med/9780198766223.003.0039
Goto, T., Nakayama, T., Yamamoto, J., Mori, K., Shintani, Y., Kikuchi, S., Fujita, H., Wakami, K., Fukuta, H., Seo, Y., et al. (2022) · Tomography · doi:10.3390/tomography8030132
Katheterablation von Vorhofflimmern – aktuelle Versorgungsstandards und Zukunftstrends
Huttelmaier, M. T., & Fischer, T. H. (2022) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/a-1477-4020
Ahn, M., Yoo, B., Lee, S. J., Kim, J., Son, J., Park, Y. J., Cho, D., Kim, S. H., Kang, D. R., Lee, H., et al. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4126910
Liew, R. (2012) · Revista Portuguesa de Cardiologia (English Edition) · doi:10.1016/j.repce.2011.11.018
Atrial Fibrillation in Heart Failure: Rate or Rhythm Control Strategy
Lubis, A. C., Munawar, D. A., & Munawar, M. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.105777
Arrhythmia Management in the Elderly
Wallace, R. L., & Calkins, H. G. (2023) · Contemporary cardiology · doi:10.1007/978-3-031-16594-8_6
Seizer, P., & Gramlich, M. (2023) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/a-1932-8085
The Nexus of Atrial Fibrillation, Heart Failure, and Cardiac Pacing Therapies in 2022
Niazi, I. K. (2023) · Journal of Innovations in Cardiac Rhythm Management · doi:10.19102/icrm.2023.14019
Cold, I. M., Feinberg, J. B., Brandes, A., Davidsen, U., Dixen, U., Domínguez, H., Gang, U. J. O., Gluud, C. N., Hadad, R., Kristensen, K. E., et al. (2023) · Trials · doi:10.1186/s13063-023-07247-7 · Cited by 1
“This recommendation is primarily based on the results of the RACE II trial [2].”
Diemberger, I., & Boriani, G. (2023) · EP Europace · doi:10.1093/europace/euad117
“) in terms of symptoms control and mortality.(6) This was translated into the official guidelines from the European Society of Cardiology, which included a Class II recommendation for lenient rate control (<110 b.”
BackgroundQuijije, J. M. M., Romero, M. J. C., Aguirre, W. G. M., Bravo, B. A. Z., Moran, L. D. M., Reyes, A. P. P., Andino, S. A. V., & Delgado, Y. F. Q. (2023) · Juan Cuevas eBooks · doi:10.56470/978-9942-627-40-7
Rate Versus Rhythm Control in Atrial Fibrillation (AFFIRM)-2002
Flanagan, S. P. (2023) · Springer eBooks · doi:10.1007/978-3-031-25620-2_7
Diagnosis and Treatment of New-Onset Perioperative Atrial Fibrillation
McCusker, R. J., Wheelwright, J., Smith, T. J., Myler, C. S., & Sinz, E. H. (2023) · Advances in Anesthesia · doi:10.1016/j.aan.2023.06.007
Heart Failure Management in Developing Countries
Siddique, A., Otaibi, F. M., & Khan, S. F. (2023) · Springer eBooks · doi:10.1007/978-3-030-74786-2_6-1
The Chronic Systolic Heart Failure Patient: Presentation and Management
Bitar, A., & Aaronson, K. D. (2023) · Wiley eBooks · doi:10.1002/9781119633884.ch13
Martín-Mojarro, E., Gil, V., Llorens, P., Flores-Quesada, S., Ungerer, O. J. T., Alquézar‐Arbé, A., Jacob, J., Herrero, P., Sánchez, C., & Miró, Ò. (2023) · Revista Clínica Española (English Edition) · doi:10.1016/j.rceng.2023.09.003
Aguilar-Molina, O. E., Montoya-Duque, A. M., Betancur-Salazar, K., Correa-Velásquez, R., Herrera-Céspedes, C. E., Ramírez-Barrera, J. D., & Agudelo-Uribe, J. F. (2023) · Revista Colombiana de Cardiología · doi:10.24875/rccar.22000091 · Cited by 2
Ancillary pharmacological treatment options
Agewall, S., Gelder, I. C. V., & Savelieva, I. (2023) · Oxford University Press eBooks · doi:10.1093/med/9780198891628.003.0051
Atrial fibrillation treatment in the emergency room: a practical narrative review
Aguilar-Molina, O. E., Montoya-Duque, A. M., Betancur-Salazar, K., Correa-Velásquez, R., Herrera-Céspedes, C. E., Ramírez-Barrera, J. D., & Agudelo-Uribe, J. F. (2023) · Revista Colombiana de Cardiología (English Edition) · doi:10.24875/rccare.m23000056
Goetze, M., Knauf, T., & Ebelt, H. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12247724
“Accordingly, an adequate rate control is achieved when the mean heart rate at rest is between 80 and 110/min [11,12].”
BackgroundFibrillation atriale et autres tachycardies
Lafuente‐Lafuente, C. (2023) · Elsevier eBooks · doi:10.1016/b978-2-294-77815-5.00027-5
Lian, C., Zhang, X., Li, J., Shi, J., Shi, S., Wang, L.-X., Guo, Z., Liu, N., Wang, H., Shi, S., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-3881463/v1
2) Comprehensive Management and Treatment of Atrial Fibrillation
Takahashi, N. (2023) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.112.356
Guía Esencial de Medicina Interna en el Primer Nivel de Atención Tomo 16
Arcentales, P. E. C., Llerena, J. D. A., Molina, M. E. Q., Quimis, C. D. A., Caldas, E. M. G., Barrezueta, A. T. G., Alvarado, C. J. C., Palacios, L. P. T., Canga, J. E. S., Tarira, J. R. V., et al. (2024) · Juan Cuevas eBooks · doi:10.56470/978-9942-660-04-6
Sex-specific association of cardiovascular drug doses with adverse outcomes in atrial fibrillationPreprint
Moor, J., Kühne, M., Moschovitis, G., Kobza, R., Netzer, S., Auricchio, A., Beer, J. H., Bonati, L. H., Reichlin, T., Conen, D., et al. (2024) · medRxiv · doi:10.1101/2024.04.20.24306039
Kaputrin, N., Rizal, A., Putri, V. Y. S., Rahimah, A. F., Rohman, M. S., Wikananda, A. P., Waranugraha, Y., Astiawati, T., & Laitupa, F. S. (2024) · Heart Science Journal · doi:10.21776/ub/hsj.2024.005.02.8
Lee, K., Kim, S., Guk, H. S., Kim, D. Y., Kim, B. J., Han, M., Kim, J.-T., Choi, K., Shin, D., Cha, J., et al. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4845124
Artificial intelligence techniques for diagnosis of atrial fibrillation
Bhardwaj, A., Bandyopadhyay, R., Kumar, R. P., Neelapu, B. C., Pal, K., & Sivaraman, J. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-19073-5.00029-x · Cited by 1
Activation of ErbB4 attenuates atrial fibrillation in mice
fraeyenhove, J. V. (2024) · doi:10.63028/10067/2044020151162165141
Impact of Atrial Fibrillation with Rapid Ventricular Response in Acute Decompensated Heart FailurePreprint
Halhal, B., Bar, O., Mohammad, S., & Aronson, D. (2024) · medRxiv · doi:10.1101/2024.06.20.24309212
Mishra, S., Biswàs, S., & Bhoriwal, S. K. (2024) · Springer eBooks · doi:10.1007/978-981-99-6339-3_7
Mehta, D., Petrovic, L., & Lee, S. Y. (2024) · JACC Advances · doi:10.1016/j.jacadv.2024.101121
New Therapeutic Strategies in Managing Atrial Fibrillation in Heart Failure
Akinrimisi, O. P., & Perez, M. V. (2024) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-024-01051-5
“…a Comparison between Lenient versus Strict Rate Control II (RACE II) trial showed that there was no statistically significant difference in outcome when comparing lenient rate control (resting heart rate less than 110 bpm) or strict rate control (resting heart rate less than 80 bpm) [15].”
Sex-specific association of cardiovascular drug doses with adverse outcomes in atrial fibrillation
Moor, J., Kühne, M., Moschovitis, G., Kobza, R., Netzer, S., Auricchio, A., Beer, J. H., Bonati, L. H., Reichlin, T., Conen, D., et al. (2024) · Open Heart · doi:10.1136/openhrt-2024-002720
Bradysystole in permanent atrial fibrillation: clinical importance and modeling in experiment
Андреевна, Г. О., Shchukin, Y. V., Galati, G., & Pedretti, R. F. E. (2024) · Science and Innovations in Medicine · doi:10.35693/sim634388
Jeong, J. H., Baek, Y., Park, J., Park, H. W., Choi, E., Park, J., Kang, K., Kim, J., Lee, Y. S., Kim, J., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13185469 · Cited by 1
Short-term and long-term outcomes of cardiac arrhythmias in patients with cardiogenic shock
Asaker, J.-C., Bansal, M., Mehta, A., Joice, M. G., Kataria, R., Saad, M. S., Abbott, J. D., & Vallabhajosyula, S. (2024) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2024.2409437
“The goal heart rate established per RACE II (The Rate Control Efficacy in Permanent Atrial Fibrillation: A Comparison between Lenient versus Strict Rate Control II) of less than 110 beats per minute is likely also reasonable in the CS patient population [38].”
Lauder, L., Pfister, O., & Mahfoud, F. (2024) · European Journal of Heart Failure · doi:10.1002/ejhf.3513
Atrial fibrillation in patients with arterial hypertension and novel European Guidelines
Havránek, Š. (2024) · Vnitřní lékařství · doi:10.36290/vnl.2024.087
Alken, F., Senges, J., Schneider, S., Hochadel, M., Brachmann, J., Kleemann, T., Eckardt, L., Steinbeck, G., Leschke, M., Stellbrink, C., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-78851-z
Rate (and Rhythm)‐Limiting Steps in Newly Diagnosed Atrial Fibrillation
Patel, R., & Wasserlauf, J. (2025) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.16616
Enge, K., Ulimoen, S. R., Enger, S., Onarheim, S., Olufsen, M., Pripp, A. H., Steinsvik, T. E., Hall, C., Hetland, M., & Tveit, A. (2025) · BMC Cardiovascular Disorders · doi:10.1186/s12872-025-04574-2
“Despite a baseline resting heart rate already below the lenient rate of 110 bpm, [30] we observed that a reduction in troponin levels accompanied a further reduction of the heart rate.”
Peng, B., Sommerville, S., Tragesser, A., & Peng, Y. (2025) · Cureus · doi:10.7759/cureus.80837
Hu, G. J., & O’Kane, C. P. (2025) · Springer eBooks · doi:10.1007/978-3-031-77335-8_13
Long, Y., Ma, X., Ren, Y., Cui, D., & Yin, Y. ‐. (2025) · Nursing in Critical Care · doi:10.1111/nicc.70027
“7 Although previous studies have proposed heart rate (HR) target for AF management, 8 this evidence is derived from non-critically ill patients.”
Yang, W. J., Jiang, Z., Wang, S., Chen, C., Zhou, X., & Shan, Q. (2025) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2025.03.044
Intractable, Life-Threatening Cardiac Arrhythmias Following MCS
Martinez, J., Bai, R., Shen, C., & SU, W. W. (2025) · Springer eBooks · doi:10.1007/978-3-030-86172-8_44-1
Questioning the Rhythm: A Closer Look at Heart Rate Trends in Atrial Fibrillation
Hassan, I. N. (2025) · Clinical Cardiology · doi:10.1002/clc.70150
Authors' Reply to “Questioning the Rhythm: A Closer Look at Heart Rate Trends”
Kodani, E., Yamashita, T., Inoue, H., Atarashi, H., Okumura, K., Origasa, H., & J‐RHYTHM Registry Investigators (2025) · Clinical Cardiology · doi:10.1002/clc.70158
Abittan, N., Tripathi, A. K., Cheikhali, R., Radwan, Y., Ostrow, T. H., Frishman, W. H., Aronow, W. S., & Lanier, G. M. (2025) · Cardiology in Review · doi:10.1097/crd.0000000000000987
Chang, J., Du, Q., Liu, Y., Li, D., Zhou, H., Liao, Y., Zhu, J., Bai, B., Liu, X., & Ma, H. (2025) · BMC Cardiovascular Disorders · doi:10.1186/s12872-025-04961-9
“However, lenient rate control offered greater convenience for both patients and healthcare providers [12, 13].”
Vorhofflimmern bei Ionenkanal-Erkrankungen und Kardiomyopathien
Kreimer, F., Gotzmann, M., & Eckardt, L. (2025) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/a-2498-1571
Sauve, J., Tang-Whitmore, C. R., Randall, Z., Meshram, P. D., Nguyen, S. H., Nigam, A., Bhagat, M., Berger, J., Diaz‐Gutierrez, I., Mogrovejo, D. O., et al. (2025) · Cureus · doi:10.7759/cureus.89426 · Cited by 2
“Therefore, lenient rate control is a reasonable initial strategy, with stricter targets reserved for patients with persistent symptoms or suspected tachycardia-induced cardiomyopathy [35,37-39].”
刘, 盼. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.1582374
Harake, L. E., Al‐Kazaz, M., & Cremer, P. C. (2025) · Current Cardiology Reports · doi:10.1007/s11886-025-02303-x
“For rate control, beta-blockers are the first-line agents, with a target resting heart rate of 100 bpm, consistent with both the 2023 ACC/AHA and 2020 ESC/EACTS guidelines [61, 64, 65].”
Zhu, W., Xu, J., & Zhang, L. (2025) · American Heart Journal Plus Cardiology Research and Practice · doi:10.1016/j.ahjo.2025.100655
“Clinically, previous studies, notably the RACE II trial [25], suggest a resting heart rate target of 110 beats per minute as adequate rate control in chronic heart failure.”
Agee, J., Baize, P., Weigartz, K., & Barre, S. (2025) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2025.11.002
Salih, M. (2025) · Springer eBooks · doi:10.1007/978-3-032-03240-9_4
Morikawa, M. J. (2025) · Springer eBooks · doi:10.1007/978-3-032-08398-2_30
Antiarrhythmic Drug Therapy for Acute Management of Atrial Fibrillation and Atrial Flutter
Habibi, M., Rahim, M. A., & Mittal, S. (2025) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2025.10.003
Calvo, N. (2013) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Turagam, M. K. (2013) · Southern Medical Journal · doi:10.1097/smj.0b013e3182967eaa
Implications of Atrial Fibrillation in Heart Failure Management
Darling, C. E., & Aghababian, R. V. (2012) · Contemporary cardiology · doi:10.1007/978-1-61779-627-2_20
Cold, I. M., Feinberg, J. B., Brandes, A., Davidsen, U., Dixen, U., Dominguez, H., Gang, U. J. O., Gluud, C., Hadad, R., Kristensen, K. E., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22624924
Cold, I. M., Feinberg, J. B., Brandes, A., Davidsen, U., Dixen, U., Dominguez, H., Gang, U. J. O., Gluud, C., Hadad, R., Kristensen, K. E., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22624927
Metadata
- Authors
- Van Gelder, I. C., Groenveld, H. F., Crijns, H. J. G. M., Tuininga, Y. S., Tijssen, J. G. P., Alings, A. M., Hillege, H. L., Bergsma-Kadijk, J. A., Cornel, J. H., Kamp, O., Tukkie, R., Bosker, H. A., Van Veldhuisen, D. J., & Van den Berg, M. P.
- Affiliations
- University Medical Center Groningen (NL)
- Maastricht University Medical Centre (NL)
- Deventer Ziekenhuis (NL)
- Amsterdam UMC Location University of Amsterdam (NL)
- Medisch Centrum Alkmaar (NL)
- Rijnstate Hospital (NL)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2010-04-15
- Volume
- 362
- Issue
- 15
- Pages
- 1363-1373
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2102129403
- Cited by
- 1,033
- References
- 19
- Citations by year
- 2026: 36 · 2025: 55 · 2024: 59 · 2023: 61 · 2022: 56 · 2021: 63 · 2020: 44 · 2019: 50 · 2018: 45 · 2017: 62 · 2016: 56 · 2015: 51 · 2014: 81 · 2013: 94 · 2012: 83
- FWCI
- 68.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Research Publications (Maastricht University) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart rate and cardiovascular health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
- Keywords
- atrial fibrillation, rate control, resting heart rate, non-inferiority, cardiovascular morbidity and mortality, heart failure hospitalization, stroke, hemorrhage, arrhythmic events, anticoagulation
- MeSH terms
- Adrenergic beta-Antagonists, Aged, Anti-Arrhythmia Agents, Atrial Fibrillation, Calcium Channel Blockers, Female, Follow-Up Studies, Heart Rate, Humans, Male, Middle Aged, Confidence Intervals, Kaplan-Meier Estimate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.